Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Bullboard Posts
Comment by Zanderron Jun 06, 2019 4:01pm
172 Views
Post# 29803781

RE:Wow This is going to be

RE:Wow This is going to be
It's looking less and less likely that anything independent will push WMD forward. Based on recent earnings it is clear now that the early projections for revenue we waayyyyy over estimated. The rollout here in Canada has been a joke and has really held everyone back. And I suspect the next Q will be the same, if they manage to hit the $5MM mark i'd be surprised at this rate. 
 
Outdoor crop won't provide any revenue until Q4 at the earliest and will only show up as a uptick in biological assets for the next quarterly release. We likely need a shift in market focus where all of a sudden WMD is the flavor of the month and then there is a surge in volume, or we need some sort of a merger or buyout or something if we want to see any huge gains. Apart from that, nothing impressive will likely come from the earnings reports until mid 2020 at the earliest.
 
It's unfortunate how the momentum can't seem to be sustained, especially with all the great news out lately. 
 
 

ForeverU138 wrote: a long long summer before.. I really didn't think we would see the 1.50's.. seriously looking to bail. What catalysts are there for a turn around before end of Sept.. buy out at this level is a bargain for bigger fish.. we may never see north of 2 for WMD as a independent entity.


Bullboard Posts